# Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer

Source: https://onco.cc/trials/nct06840483/  
OnCo record `nct06840483` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Zelenectide pevedotin in advanced solid tumours, run by BicycleTx Limited, active and no longer recruiting.

## Summary

Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer is a phase 2 interventional study registered as NCT06840483 by BicycleTx Limited, with 66 participants enrolled, started 2025-03-03 and due to reach its primary completion in 2028-06-30. Interventions recorded: Zelenectide pevedotin (BT8009).

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06840483
- Phase: 2
- Setting: Phase 2 Study of Zelenectide Pevedotin in Participants With NECTIN4 Amplified Advanced Breast Cancer
- Sponsor: BicycleTx Limited
- Enrolled: 66

## Sources

- ClinicalTrials.gov NCT06840483: https://clinicaltrials.gov/study/NCT06840483

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)
- drugs: [Zelenectide pevedotin](https://onco.cc/drugs/zelenectide-pevedotin/)

---
JSON: https://onco.cc/api/v1/entities/nct06840483.json